Roflumilast, a phosphodiesterase-4 inhibitor, induces phagocytic activity in Greek COPD patients

Roflumilast, a phosphodiesterase-4 inhibitor, induces phagocytic activity in Greek COPD patients

Konstantinos Porpodis,1 Kalliopi Domvri,1 Paul Zarogoulidis,1 Dimitrios Petridis,2 Katerina Tsirgogianni,1 Antonis Papaioannou,1 Olga Hatzizisi,3 Ioannis Kioumis,1 Alexandra Liaka,3 Violeta Kikidaki,3 Sofia Lampaki,1 John Organtzis,1 Konstantinos Zarogoulidis1 1Pulmonary Department-Oncology Unit, G...

Full description

Bibliographic Details
Main Authors: Porpodis K, Domvri K, Zarogoulidis P, Petridis D, Tsirgogianni K, Papaioannou A, Hatzizisi O, Kioumis I, Liaka A, Kikidaki V, Lampaki S, Organtzis J, Zarogoulidis K
Format: Article
Language:English
Published: Dove Medical Press 2015-06-01
Series:International Journal of COPD
Online Access:http://www.dovepress.com/roflumilast-a-phosphodiesterase-4nbspinhibitor-induces-phagocytic-acti-peer-reviewed-article-COPD

Internet

http://www.dovepress.com/roflumilast-a-phosphodiesterase-4nbspinhibitor-induces-phagocytic-acti-peer-reviewed-article-COPD

Similar Items